Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Paclitaxel-succinate-Arg-Arg-Leu-Ser-Tyr-Ser-Arg-Arg-Arg-Phe

EU orphan designation number: EU/3/14/1274   
Active ingredient: Paclitaxel-succinate-Arg-Arg-Leu-Ser-Tyr-Ser-Arg-Arg-Arg-Phe
Indication: Treatment of glioma
Sponsor: Orphit
1093 Chemin des Plateaux, Fleuris Résidences Panoramiques Villa B, 06700 Saint-Laurent-Du-Var, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
06/06/2014 Orphan designation EMA/OD/003/14 (2014)3861 of 04/06/2014
11/05/2015 Transfer of orphan designation EMA/OD/003/14/T/01 (2015)3245 of 07/05/2015